Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALLO-ASC-DFU in Diabetic Foot Ulcers
NCT02619877Phase 2Completed
- Sponsor
- Anterogen Co., Ltd.
- Start
- Oct 2015
- Primary completion
- Sep 2016
- Modality
- Mesenchymal Stem Cells
- Countries
- 1
01
Overview
A Phase 2 trial of allo-asc in diabetic foot ulcer (DFU), sponsored by Anterogen Co., Ltd.. Started Oct 2015; status: completed.
02
Drugs
allo-asc
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT02619877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02619877.